Russell Investments Group, Ltd. - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 91 filers reported holding OVID THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$219
-100.0%
57
-100.0%
0.00%
-100.0%
Q1 2023$690,042
+38.1%
267,459
-0.5%
0.00%0.0%
Q4 2022$499,808
+1.6%
268,7150.0%0.00%0.0%
Q3 2022$492,000
-14.3%
268,715
+0.3%
0.00%0.0%
Q2 2022$574,000
-33.6%
267,868
-2.9%
0.00%
-50.0%
Q1 2022$865,000
-12.0%
275,973
-10.0%
0.00%0.0%
Q4 2021$983,000
+134.6%
306,556
+194.0%
0.00%
+100.0%
Q1 2021$419,000
+41800.0%
104,283
+20756.6%
0.00%
Q4 2018$1,0005000.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
AWH Capital, L.P. 230,000$407,0000.69%
BVF INC/IL 3,293,000$5,829,0000.65%
COWEN INC. 1,101,414$1,950,0000.21%
ARMISTICE CAPITAL, LLC 1,780,000$3,151,0000.17%
Granite Point Capital Management, L.P. 417,857$740,0000.07%
Redmile Group, LLC 737,550$1,305,0000.04%
Tekla Capital Management LLC 496,977$880,0000.04%
Fairpointe Capital LLC 101,000$179,0000.01%
Alyeska Investment Group, L.P. 225,000$398,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,440$149,0000.00%
View complete list of OVID THERAPEUTICS INC shareholders